Omez (Omeprazole)

Omeprazole, the active ingredient in Omez, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to manage acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omez as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omez as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omez is a proton pump inhibitor that acts on the gastric acid secretion pathway to treat several acid‑related disorders.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the condition. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSAID‑induced gastropathy: helps prevent ulcer formation in patients requiring long‑term NSAID therapy.

Adverse reactions to Omez may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: infrequent but reported.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: renal inflammation. - Hypomagnesemia: low serum magnesium levels. - Stevens‑Johnson syndrome: severe skin reaction. - Liver enzyme elevation: potential hepatic impact. - Fracture risk: possible reduction in bone mineral density with long‑term use.

When prescribing Omez, clinicians should consider several safety aspects.

- Assess renal function: adjust use in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor magnesium levels: especially during prolonged therapy. - Evaluate bone health: consider calcium/vitamin D supplementation for long‑term users. - Pregnancy and lactation: use only if clearly needed. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omez can interact with several medicines, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atorvastatin: increased exposure leading to possible toxicity. - Methotrexate: heightened serum levels, especially with high‑dose regimens.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR values. - Digoxin: modest increase in serum concentration. - HIV protease inhibitors: altered absorption of both agents.